RITUXIMAB vs RIVASTIGMINE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
RITUXIMAB vs RIVASTIGMINE: Safety Overview
| Metric | RITUXIMAB | RIVASTIGMINE |
|---|---|---|
| Total FAERS Reports | 178,614 | 9,123 |
| Deaths Reported | 28,910 | 2,232 |
| Death Rate | 16.2% | 24.5% |
| Hospitalizations | 54,631 | 2,716 |
| Average Patient Age | 54.6 yrs | 80.0 yrs |
| % Female Patients | 64.3% | 59.5% |
| FDA Approval Date | N/A | Apr 21, 2000 |
| Manufacturer | Genentech, Inc. | Novartis Pharmaceuticals Corporation |
| Route | INTRAVENOUS | TRANSDERMAL |
| Marketing Status | Prescription | Discontinued |